Sugar pill or savior? supplement may cut insulin use in pregnancy diabetes
NCT ID NCT03875755
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether myo-inositol, an oral dietary supplement, can help pregnant women with gestational diabetes control their blood sugar without needing insulin shots. About 1,080 women with newly diagnosed gestational diabetes will receive either myo-inositol or a placebo alongside standard diet and lifestyle advice. The goal is to see if the supplement reduces the number of women who require insulin therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hopital Avicenne
Bobigny, France
-
Hôpital Avicenne
Bobigny, 93000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a phone app tame gestational diabetes?
- Five minutes a day: breathing training may tame pregnancy blood pressure
- Birth cohort study aims to uncover roots of Youth-Onset type 2 diabetes in indigenous communities
- Simple alerts may keep At-Risk moms healthy after birth
- Blood sugar tracker for pregnancy diabetes: does your background matter?
- Diet coaching for gestational diabetes: a closer look at what works